3rd Annual Inhaled & Nasal Biologics/DNA Forum 2024

We are delighted to announce that we are hosting the 3rd edition of the Annual Inhaled and Nasal Biologics/DNA Forum in September 2024. We invite you to join two days of cutting-edge talks and networking opportunities with leaders in this complex area of drug product development.

Biologics and nucleotide-based therapeutics have gained increasing importance in the last decade. Pulmonary and intranasal delivery of these presents a compelling, non-invasive alternative to traditional parenteral methods, offering potential for both local respiratory and systemic treatments across a variety of diseases and indications. However, biologics, mRNA, nucleotide-based therapeutics and vaccines present unique challenges for respiratory administration and whilst there can be many ways to design a product, the developer needs to balance, amongst many other things, product performance, manufacturability, regulatory risk, and commercial elements.